106 related articles for article (PubMed ID: 30776504)
1. WIN55,212-2 induces caspase-independent apoptosis on human glioblastoma cells by regulating HSP70, p53 and Cathepsin D.
Silva AG; Lopes CFB; Carvalho Júnior CG; Thomé RG; Dos Santos HB; Reis R; Ribeiro RIMA
Toxicol In Vitro; 2019 Jun; 57():233-243. PubMed ID: 30776504
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
3. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.
Scuderi MR; Cantarella G; Scollo M; Lempereur L; Palumbo M; Saccani-Jotti G; Bernardini R
Cancer Lett; 2011 Nov; 310(2):240-9. PubMed ID: 21807457
[TBL] [Abstract][Full Text] [Related]
4. [Cannabinoid WIN55, 212-2 inhibits proliferation, invasion and migration of human SMMC-7721 hepatocellular carcinoma cells].
Wang J; Deng Y; Tan Y; Li K; Wen B; Zhao Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 May; 32(5):619-24. PubMed ID: 27126940
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.
Wang K; Wang Q; Li Q; Zhang Z; Gao J; Fan C; Sun B; Ni Q
Biomed Res Int; 2021; 2021():6612592. PubMed ID: 33977107
[TBL] [Abstract][Full Text] [Related]
6. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
Roberto D; Klotz LH; Venkateswaran V
Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.
McAllister SD; Chan C; Taft RJ; Luu T; Abood ME; Moore DH; Aldape K; Yount G
J Neurooncol; 2005 Aug; 74(1):31-40. PubMed ID: 16078104
[TBL] [Abstract][Full Text] [Related]
9. The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner.
Curran NM; Griffin BD; O'Toole D; Brady KJ; Fitzgerald SN; Moynagh PN
J Biol Chem; 2005 Oct; 280(43):35797-806. PubMed ID: 16105834
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bcl-xL gene expression.
Pozzoli G; Tringali G; Vairano M; D'Amico M; Navarra P; Martire M
J Neurosci Res; 2006 May; 83(6):1058-65. PubMed ID: 16609959
[TBL] [Abstract][Full Text] [Related]
11. PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells.
Hong Y; Zhou Y; Wang Y; Xiao S; Liao DJ; Zhao Q
Mol Biol Rep; 2013 Nov; 40(11):6287-93. PubMed ID: 24062073
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.
Xu D; Wang J; Zhou Z; He Z; Zhao Q
Mol Med Rep; 2015 Dec; 12(6):7963-70. PubMed ID: 26500101
[TBL] [Abstract][Full Text] [Related]
13. The synthetic cannabinoid WIN-55,212 induced-apoptosis in cytotrophoblasts cells by a mechanism dependent on CB1 receptor.
Almada M; Costa L; Fonseca BM; Amaral C; Teixeira N; Correia-da-Silva G
Toxicology; 2017 Jun; 385():67-73. PubMed ID: 28495606
[TBL] [Abstract][Full Text] [Related]
14. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
16. WIN55,212-2-Induced Expression of Mir-29b1 Favours the Suppression of Osteosarcoma Cell Migration in a SPARC-Independent Manner.
Notaro A; Emanuele S; Geraci F; D'Anneo A; Lauricella M; Calvaruso G; Giuliano M
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652569
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
Scholl A; Ivanov I; Hinz B
Oncotarget; 2016 Sep; 7(38):61438-61457. PubMed ID: 27556861
[TBL] [Abstract][Full Text] [Related]
18. [The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells].
Wang Y; Zhou YT; Zhao Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):344-7. PubMed ID: 20368112
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.
Giuliano M; Pellerito O; Portanova P; Calvaruso G; Santulli A; De Blasio A; Vento R; Tesoriere G
Biochimie; 2009 Apr; 91(4):457-65. PubMed ID: 19059457
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1.
Kong Y; Wang W; Zhang C; Wu Y; Liu Y; Zhou X
Mol Med Rep; 2016 Jun; 13(6):4569-76. PubMed ID: 27082728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]